Skip to content

US · NXTS · AGRICULTURAL INPUTS

Nexentis Technologies Inc. (NXTS) intrinsic value and stock valuation

$1.58as of 2026-11-21 · Mkt cap 104.7K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Nexentis Technologies Inc. DCF and intrinsic value

InvestorsCraft values NXTS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from NXTS’s statements →

Nexentis Technologies Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Basic Materials · Agricultural Inputs Ness Ziona, TA 7403626 nexentistech.com

How the business is doing

Fiscal 2009–2025, USD

Revenue
$0.00
20092025
Net income
-$-4.05M
20092025
Free cash flow
-$-3.82M
20092025
Total equity
$15.7M
20092025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2009–2025, USD
20252024202320222021
Revenue$0.00$210K$260K$390K$440K
Operating income-$-5.03M-$-4.05M-$-7.3M-$-5.71M-$-4.54M
Net income-$-4.05M-$-5.19M-$-6.52M-$-5.74M-$-4.82M
EPSd-$-25.31M-$-30.53M-$-217.33M-$-574M-$-482M
Operating cash flow-$-3.81M-$-3.42M-$-3.23M-$-5.1M-$-4.1M
Capital expenditure-$-10K$0.00-$0.00-$-50K-$-70K
Free cash flow-$-3.82M-$-3.42M-$-3.23M-$-5.15M-$-4.17M
Total assets$20.4M$5.46M$7.24M$6.49M$7.6M
Total debt$990K$10K$50K$150K$230K
Net debt-$-2.84M-$-2.2M-$-4.42M-$-5.6M-$-6.58M
Total equity$15.7M$4.57M$6.46M$5.74M$6.41M
Cash and short-term investments$4.07M$2.52M$4.48M$5.75M$6.81M
Income statement
20252024202320222021
Revenue$0.00$210K$260K$390K$440K
Cost of revenue$80K$180K$80K$190K$190K
Gross profit-$-80K$30K$190K$210K$240K
Research and development expenses$180K$370K$1.93M$750K$500K
Selling, general and administrative expenses$5.11M$3.71M$5.56M$5.17M$4.29M
Other expenses-$-340K$0.00$0.00$0.00$0.00
Operating expenses$4.95M$4.08M$7.49M$5.92M$4.79M
Cost and expenses$5.03M$4.26M$7.56M$6.1M$4.98M
Interest income$0.00$70K$70K$0.00$0.00
Interest expense$120K$100K$10K$10K$40K
Depreciation and amortization$80K$20K$20K$50K$60K
Ebitda-$-4.95M-$-4.03M-$-7.28M-$-5.66M-$-4.48M
Operating income-$-5.03M-$-4.05M-$-7.3M-$-5.71M-$-4.54M
Total other income/expenses, net$1.42M-$-1.3M$40K-$-70K-$-320K
Income before tax-$-3.61M-$-5.35M-$-7.26M-$-5.78M-$-4.87M
Income tax expense-$-20K$0.00$0.00$0.00$0.00
Net income-$-4.05M-$-5.19M-$-6.52M-$-5.74M-$-4.82M
Weighted average shares outstanding$160K$170K$30K$10K$10K
Weighted average diluted shares outstanding$160K$170K$30K$10K$10K
Balance sheet
20252024202320222021
Cash and short-term investments$4.07M$2.52M$4.48M$5.75M$6.81M
Net receivables$530K$380K$110K$190K$170K
Inventory$0.00$20K$120K$80K$20K
Total current assets$6.01M$3.4M$5.47M$6.27M$7.23M
Property, plant and equipment, net$40K$60K$120K$220K$230K
Goodwill and intangible assets$11.4M$0.00$0.00$0.00$0.00
Long-term investments$2.74M$1.76M$1.66M$0.00$0.00
Total non-current assets$14.4M$2.06M$1.78M$220K$370K
Total assets$20.4M$5.46M$7.24M$6.49M$7.6M
Accounts payable$10K$50K$40K$420K$540K
Short-term debt$750K$10K$40K$70K$50K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$1.43M$890K$780K$710K$930K
Long-term debt$240K$0.00$10K$80K$170K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$3.24M$0.00$10K$40K$250K
Capital lease obligations$10K$0.00$10K$40K$90K
Total liabilities$4.67M$890K$790K$750K$1.18M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-38.56M-$-34.55M-$-29.36M-$-22.84M-$-17.1M
Accumulated other comprehensive income (loss)-$-40K-$-30K-$-30K-$-30K-$-30K
Total equity$15.7M$4.57M$6.46M$5.74M$6.41M
Total investments$2.98M$2.07M$1.66M$0.00$0.00
Total debt$990K$10K$50K$150K$230K
Net debt-$-2.84M-$-2.2M-$-4.42M-$-5.6M-$-6.58M
Cash flow statement
20252024202320222021
Net income-$-4.16M-$-5.19M-$-6.52M-$-5.74M-$-4.82M
Depreciation and amortization$70K$20K$20K$50K$60K
Stock-based compensation$2.15M$0.00$0.00$0.00$0.00
Change in working capital-$-100K$170K$290K-$-270K-$-50K
Accounts receivable$10K-$-40K$90K-$-20K-$-20K
Inventory$10K$100K-$-40K-$-60K-$-10K
Accounts payable-$-20K$10K-$-90K-$-120K$340K
Net cash provided by operating activities-$-3.81M-$-3.42M-$-3.23M-$-5.1M-$-4.1M
Investments in property, plant and equipment-$-10K$0.00$0.00-$-50K-$-70K
Acquisitions, net-$-2.35M-$-1.01M$20K$0.00$0.00
Net cash used for investing activities-$-3.23M-$-1.89M-$-1.52M-$-50K-$-80K
Common stock issued$3.33M$0.00$0.00$4.1M$10.5M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$8.86M$3.05M$3.47M$4.09M$10.7M
Net change in cash$1.8M-$-2.27M-$-1.27M-$-1.06M$6.54M
Cash at end of period$4.01M$2.21M$4.48M$5.75M$6.81M
Operating cash flow-$-3.81M-$-3.42M-$-3.23M-$-5.1M-$-4.1M
Capital expenditure-$-10K$0.00-$0.00-$-50K-$-70K
Free cash flow-$-3.82M-$-3.42M-$-3.23M-$-5.15M-$-4.17M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Nexentis Technologies Inc.

        Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

        CEO
        David Palach
        Employees
        7
        Beta
        1.82

        Explore

        Frequently asked questions

        What is the intrinsic value of Nexentis Technologies Inc. (NXTS)?

        InvestorsCraft does not currently publish an intrinsic value for NXTS. How the IC value is calculated.

        Is NXTS undervalued?

        InvestorsCraft does not publish an undervaluation signal for NXTS at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.